You are viewing: US Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The US Biopreservation Market was valued at $777.3 Million in 2024 and projected to reach to $1234 Million by 2029, representing a compound annual growth rate of 9.7%. The US biopreservation market is positioned for sustained growth through 2029, driven by expanding cell therapy pipelines, regenerative medicine breakthroughs, and increasing organ transplantation demand.

US Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Biopreservation Market Trends and Insights

  • This expansion reflects the US healthcare sector's increasing reliance on advanced preservation technologies for cell therapies, regenerative medicine, and organ transplantation.
  • The US market benefits from strong regulatory frameworks, substantial R&D investments, and a mature healthcare infrastructure that prioritizes innovation in biopreservation solutions. Driving this growth, the US biopreservation market is supported by rising demand for cryopreservation services, growing adoption of personalized medicine, and expanding clinical applications across the US.
  • The US pharmaceutical and biotechnology industries are investing heavily in biopreservation capabilities to support drug development pipelines and clinical trials.
  • Between 2024 and 2029, the US market will continue to consolidate around advanced cryogenic technologies and automated preservation systems that enhance cell viability and reduce operational costs..

Key Market Statistics

  • CAGR (2024-2029) 9.7% CAGR
  • Market Size, 2024 ~USD 777.3 Million
  • Forecast, 2029 ~USD 1234 Million
  • Country US

US Biopreservation Market Overview

Market Valuation :

The US biopreservation market reached $777.3 million in 2024, with projections to grow to $1,234 million by 2029, representing a strong 9.7% CAGR driven by advancing cell therapy and regenerative medicine applications.

Regulatory Advantage :

The US benefits from robust FDA regulatory frameworks and established guidelines for biopreservation technologies, enabling faster market entry and adoption of innovative preservation solutions across clinical and research settings.

R&D Investment :

Substantial US government and private sector R&D funding in regenerative medicine, CAR-T cell therapies, and organ transplantation is accelerating biopreservation technology development and commercialization.

Clinical Application Growth :

Increasing adoption of cryopreservation and advanced preservation techniques in US hospitals and research institutions for cell therapies, stem cell banking, and organ transplantation is fueling market expansion.

US Biopreservation Market Dynamics

  • Healthcare providers are investing heavily in advanced preservation infrastructure to support FDA-approved therapies and clinical trials.
  • The market will benefit from technological innovations in cryopreservation, automated systems, and monitoring solutions.
  • Regulatory clarity and reimbursement improvements will further accelerate adoption across hospitals, research institutions, and biotech companies, solidifying the US as a leading biopreservation market globally..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • The US biopreservation market is valued at $777.3 million in 2024 and will reach $1,234 million by 2029, representing a 9.7% CAGR.
    • The US market is driven by increasing adoption of cell and gene therapies, regenerative medicine applications, and organ transplantation protocols.
    • Advanced cryopreservation technologies and automated preservation systems are becoming standard across US biotech and pharmaceutical facilities.
    • The US regulatory environment and strong healthcare infrastructure position the country as a leader in biopreservation innovation and adoption.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    US Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    US: BIOPRESERVATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BIOBANKS588.3657.1726.3801.1886.2979.81085.2120510.7
    GENE BANKS3143493834204615065576159.9
    HOSPITALS2552833093393714074474929.7
    OTHER END USERS1651831992182382612863149.6
    TOTAL1322.31472.11617.31778.11956.22153.82375.2262610.2

    Target Audience

    • Biotech & Pharma Companies : Need US market intelligence to guide cell therapy commercialization, biopreservation technology development, and go-to-market strategies for FDA-regulated products.
    • Healthcare Providers & Hospitals : Require market data to evaluate biopreservation system investments, assess vendor solutions, and plan infrastructure upgrades for cell therapy and transplantation programs.
    • Medical Device Manufacturers : Seek US market insights to develop competitive biopreservation equipment, understand clinical adoption barriers, and identify unmet needs in preservation technology.
    • Investment & Private Equity Firms : Need comprehensive US market analysis to evaluate biopreservation company valuations, identify acquisition targets, and assess sector growth potential and ROI.
    • Research Institutions & Academic Centers : Require market trends and funding data to support grant applications, justify biopreservation infrastructure investments, and align research initiatives with clinical demand.

    Reasons to Buy this Report

    • Market Size & Growth Data : Access precise US market valuation ($777.3M in 2024) and 5-year forecasts with 9.7% CAGR to support strategic planning, investment decisions, and competitive positioning in the biopreservation sector.
    • Regulatory & Compliance Insights : Understand FDA frameworks, regulatory pathways, and compliance requirements specific to US biopreservation technologies, enabling faster product development and market entry strategies.
    • Clinical Application Trends : Identify growth opportunities in US cell therapy, regenerative medicine, and organ transplantation segments with detailed adoption rates and clinical institution demand patterns.
    • Competitive Landscape Analysis : Benchmark against US market leaders, emerging players, and technology innovations to inform product development, partnerships, and market differentiation strategies.
    • Investment & Funding Opportunities : Leverage US R&D investment data and healthcare sector funding trends to identify partnership opportunities, acquisition targets, and venture capital prospects in biopreservation.

    Frequently asked questions

    What is the current size of the US biopreservation market?

    The US biopreservation market was valued at $777.3 million in 2024 and is expected to grow to $1,234 million by 2029.

    What is the projected growth rate for the US biopreservation market?

    The US biopreservation market is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2029.

    What are the primary drivers of growth in the US biopreservation market?

    Key drivers include rising demand for cell and gene therapies, expansion of regenerative medicine applications, increased organ transplantation procedures, and substantial R&D investments by US pharmaceutical and biotechnology companies.

    Which technologies are leading the US biopreservation market?

    Advanced cryopreservation systems, automated preservation platforms, and liquid nitrogen-based storage solutions are among the leading technologies driving the US market forward.

    How does the US biopreservation market compare to global trends?

    The US market grows at 9.7% CAGR, slightly below the global average of 9.8%, but represents the largest absolute market value due to the US healthcare sector's advanced infrastructure and high adoption rates.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status